Montelukast
Top View
- 2021 Essential Asthma Drug List
- Pharmacological Treatment Options and Tier Coverage for Copd/Asthma
- Genome-Wide Association Study of Leukotriene Modifier Response In
- Montelukast and Churg-Strauss Syndrome R Solans, J a Bosch, a Selva, R Orriols, M Vilardell
- 3. Respiratory System
- Drug Development for Asthma and COPD: a Regulatory Perspective
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- View by the Editor of This Journal
- A Double-Blind Non-Inferiority Clinical Study of Montelukast, a Cysteinyl
- WO 2012/163792 Al 6 December 2012 (06.12.2012) P O P C T
- Move up and Down Steps As Necessary As Steps Down and up Move Spiriva Respimat® 2.5Mcg Spiriva Respimat® 2.5Mcg
- Long-Acting Asthma and COPD Drugs Drug Effectiveness Review Project Summary Report
- Identification of Peracetylated Quercetin As a Selective 12-Lipoxygenase Pathway Inhibitor in Human Platelets
- Cayman--Eicosanoids.Pdf
- Contraindications.---'
- Leukotriene Modifiers
- Interactive Inhibitory Effects of Formoterol and Montelukast on Activated Human Neutrophils 1Gravett CM, 1Theron AJ, 1Steel HC
- Leukotriene Modifiers, Cromolyn, Theophylline: Search Strategies